Hippo pathway is regulated by cell density, cell contact, and related to cell proliferation (Huang
et al.
2005; Kim
et al.
2011; Mori
et al.
2014), apoptosis (Lee and Yonehara
2012) and organ size regulation (Camargo
et al.
2007; Zhao
et al.
2007). Hippo pathway is commonly used to coordinate organ development and control tissue homeostasis by regulating cell proliferation, apoptosis, migration and differentiation. Hippo pathway also regulates stem cell self-renewal and tissue regeneration (Mo
et al.
2014; Ramos and Camargo
2012). Hippo pathway is composed of a series of kinases including transcription coactivators and DNA binding proteins. Although Hippo pathway was first found in
Drosophila, it is also highly conserved in mammals. In mammals, Hippo pathway is mainly composed of upstream sterile 20 like kinase (MST1/2) and its scaffold protein Salvador (SAV), midstream tumor suppressor (LATS1/2) and its regulatory protein MOB, and downstream transcription effector Yes-associated protein (YAP) and transcriptional coactivator with PDZ binding motif (TAZ) (Chen
et al.
2019). At high density, the Hippo signaling pathway is opened, and the protein kinase MST1/2 activates LAST1/2 through phosphorylation. YAP is highly phosphorylated and bound with 14-3-3 protein and remains in the cytoplasm, thus inhibiting the transcription and expression of YAP downstream genes and inhibiting cell proliferation. On the contrary, under low density conditions, Hippo pathway is inhibited. YAP/TAZ complete the dephosphorylation process, and cannot bind with 14-3-3 protein, and then enter the nucleus to bind with TEAD, inducing downstream gene transcription expression and promoting cell proliferation (Lei
et al. 2008). At first, the research on Hippo pathway mainly focused on the control of tissue and organ size. In recent years, studies have confirmed that Hippo pathway has the function of regulating stem cell self-renewal and tissue regeneration.